Molecular Modeling Techniques Applied to the Design of Multitarget Drugs: Methods and Applications

Larissa Henriques Evangelista Castro1, Carlos Mauricio R Sant'Anna1,2

  • 1Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, Brasil.

Insights

Designing multitarget drugs offers advantages over traditional single-target approaches for complex diseases like cancer and diabetes. Computer-aided design, including machine learning, is advancing the development of effective multitarget ligands.

Area of Science:

  • Pharmacology and Computational Chemistry
  • Drug Discovery and Development

Background:

  • Multifactorial diseases like cancer and diabetes challenge the traditional "one-target, one-disease" drug design model.
  • Multitarget drugs offer potential advantages over drug combinations, including improved efficacy, reduced adverse effects, and lower resistance development.

Purpose of the Study:

  • To review Structure-Based Drug Design (SBDD) and Ligand-Based Drug Design (LBDD) techniques for multitarget drug discovery.
  • To highlight the challenges and advancements in designing drugs that modulate multiple targets effectively.

Main Methods:

  • Discussion of established SBDD and LBDD methodologies adapted for multitarget drug design.
  • Exploration of novel approaches, including machine-learning techniques, to address design complexities.
  • Review of case studies demonstrating successful multitarget ligand development.

Main Results:

  • Computer-aided design techniques are applicable to multitarget drug discovery.
  • Adaptation and development of novel computational methods are crucial for overcoming design challenges.
  • Successful identification of effective multitarget ligands has been achieved using these techniques.

Conclusions:

  • Multitarget drug design is a promising strategy for complex diseases.
  • Computational approaches, particularly machine learning, are vital for advancing multitarget drug discovery.
  • Further development of SBDD and LBDD techniques will enhance the creation of effective multitarget therapeutics.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.0K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
290